TY - JOUR
T1 - Erratum
T2 - Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: An international prospective cohort of BRCA1 and BRCA2 mutation carriers (Breast Cancer Res (2020) 22 (8) DOI: 10.1186/s13058-020-1247-4)
AU - HEBON
AU - Mavaddat, Nasim
AU - Antoniou, Antonis C.
AU - Mooij, Thea M.
AU - Hooning, Maartje J.
AU - Heemskerk-Gerritsen, Bernadette A.
AU - Noguès, Catherine
AU - Gauthier-Villars, Marion
AU - Caron, Olivier
AU - Gesta, Paul
AU - Pujol, Pascal
AU - Lortholary, Alain
AU - Barrowdale, Daniel
AU - Frost, Debra
AU - Evans, D. Gareth
AU - Izatt, Louise
AU - Adlard, Julian
AU - Eeles, Ros
AU - Brewer, Carole
AU - Tischkowitz, Marc
AU - Henderson, Alex
AU - Cook, Jackie
AU - Eccles, Diana
AU - Van Engelen, Klaartje
AU - Mourits, Marian J.E.
AU - Ausems, Margreet G.E.M.
AU - Koppert, Linetta B.
AU - Hopper, John L.
AU - John, Esther M.
AU - Chung, Wendy K.
AU - Andrulis, Irene L.
AU - Daly, Mary B.
AU - Buys, Saundra S.
AU - Benitez, Javier
AU - Caldes, Trinidad
AU - Jakubowska, Anna
AU - Simard, Jacques
AU - Singer, Christian F.
AU - Tan, Yen
AU - Olah, Edith
AU - Navratilova, Marie
AU - Foretova, Lenka
AU - Gerdes, Anne Marie
AU - Roos-Blom, Marie José
AU - Van Leeuwen, Flora E.
AU - Arver, Brita
AU - Olsson, Håkan
AU - Schmutzler, Rita K.
AU - Engel, Christoph
AU - Kast, Karin
AU - Phillips, Kelly Anne
N1 - Publisher Copyright: © 2020 The Author(s). Reference:. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/2/26
Y1 - 2020/2/26
N2 - After publication of the original article [1], we were notified that columns in Table 2 were erroneously displayed.
AB - After publication of the original article [1], we were notified that columns in Table 2 were erroneously displayed.
UR - http://www.scopus.com/inward/record.url?scp=85080142212&partnerID=8YFLogxK
U2 - https://doi.org/10.1186/s13058-020-01259-w
DO - https://doi.org/10.1186/s13058-020-01259-w
M3 - Comment/Letter to the editor
C2 - 32102695
SN - 1465-5411
VL - 22
JO - Breast Cancer Research
JF - Breast Cancer Research
IS - 1
M1 - 25
ER -